Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Varenicline

Catalog No. T4246LCas No. 249296-44-4
Alias CP526555, CP 526555

Varenicline (CP 526555) is a selective partial agonist of the α4β2 nAChR and a full agonist of the α3β4 nAChR and α7 nAChR to help smokers with cardiovascular disease and COPD quit smoking.

Varenicline

Varenicline

Catalog No. T4246LAlias CP526555, CP 526555Cas No. 249296-44-4
Varenicline (CP 526555) is a selective partial agonist of the α4β2 nAChR and a full agonist of the α3β4 nAChR and α7 nAChR to help smokers with cardiovascular disease and COPD quit smoking.
Pack SizePriceAvailabilityQuantity
5 mg$55In Stock
10 mg$85In Stock
25 mg$175In Stock
50 mg$265In Stock
100 mg$415In Stock
1 mL x 10 mM (in DMSO)$61In Stock
Bulk & Custom
Add to Cart
Questions
View More
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Varenicline (CP 526555) is a selective partial agonist of the α4β2 nAChR and a full agonist of the α3β4 nAChR and α7 nAChR to help smokers with cardiovascular disease and COPD quit smoking.
In vitro
Varenicline treatment at a concentration of 200 μM for 24 hours has no significant effect on the viability of HUVEC cells. At a concentration of 100 μM for 30 minutes, Varenicline significantly activates the ERK1/2 and p38 signaling pathways in HUVEC cells, which subsequently leads to reduced expression of VE-cadherin after 24 hours of treatment at the same concentration. Additionally, Varenicline treatment at 100 μM for 4 hours promotes a 2.4-fold increase in HUVEC cell migration.[3]
In vivo
Varenicline administered subcutaneously at doses of 0.5 and 1 mg/kg immediately reversed fentanyl-induced respiratory depression in rats in a dose-dependent manner and mildly alleviated the sedative effects of fentanyl. [4]
Additionally, when administered via intravenous infusion at 0.004–0.04 mg/kg/h for 23 hours per day over 7–10 days, Varenicline dose-dependently reduced self-administration of nicotine (0.0032 mg/kg/injection) alone and in combination with cocaine (0.0032 mg/kg/injection) in adult rhesus monkeys with a history of cocaine and nicotine use, without significantly affecting food-maintained responses. [5]
Moreover, Varenicline given orally at doses of 0.178–5.6 mg/kg, demonstrated antidepressant-like effects in the forced swim test in both C57BL/6J and CD-1 mice. [6]
AliasCP526555, CP 526555
Chemical Properties
Molecular Weight211.26
FormulaC13H13N3
Cas No.249296-44-4
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
H2O: 10 mg/mL (47.34 mM), Sonication is recommended.
DMSO: 10 mg/mL (47.34 mM), Sonication is recommended.
Solution Preparation Table
H2O/DMSO
1mg5mg10mg50mg
1 mM4.7335 mL23.6675 mL47.3350 mL236.6752 mL
5 mM0.9467 mL4.7335 mL9.4670 mL47.3350 mL
10 mM0.4734 mL2.3668 mL4.7335 mL23.6675 mL
20 mM0.2367 mL1.1834 mL2.3668 mL11.8338 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Varenicline | purchase Varenicline | Varenicline cost | order Varenicline | Varenicline chemical structure | Varenicline in vivo | Varenicline in vitro | Varenicline formula | Varenicline molecular weight